The stock of Cargo Therapeutics CRGX, -3.13%, a clinical-stage biotech specializing in cancer treatments, rose 2.2% in its trading debut on Friday. The deal
Quarterly results from the United States’ largest cannabis company, Curaleaf Holdings Inc., and from Canada’s Canopy Growth Corp. missed analyst estimates, while shares of
By Ben Glickman Doximity lifted its full-year outlook for revenue and adjusted earnings before interest, taxes, depreciation and amortization with fiscal second-quarter results. The